Drugs / Omega-3 EFA Supplement
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01102257 | Jan → Jul 2010 | dry eye syndrome | Asbell, Penny, M.D. | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omega-3 EFA Supplement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01102257 ↗ |